Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit

By de Haan L.   Holtrop M.   Verweij W.R.   Agsteribbe E.   Wilschut J.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 260-266

Elsevier

Access to resources Recommend Favorite

Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine

By Komase K.   Tamura S.-i.   Matsuo K.   Watanabe K.   Hattori N.   Odaka A.   Suzuki Y.   Kurata T.   Aizawa C.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 248-254

Elsevier

Access to resources Recommend Favorite

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

By Lu X.   Clements J.D.   Katz J.M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1019-1029

Elsevier

Access to resources Recommend Favorite

Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin

By Byrd W.   Cassels F.J.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1884-1893

Elsevier

Access to resources Recommend Favorite

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

By Chong C.   Friberg M.   Clements J.D.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 732-740

Elsevier

Access to resources Recommend Favorite